The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.

GST collection on account of GST of Centre (CGST+IGST+ compensation cess) during FY21 is Rs 5.48 lakh crore compared to Rs 5.99 lakh crore in FY21

Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofis Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year

Share of Adani Ports touched an intraday low of Rs 704, falling 5.44% against previous close of Rs 744.50 on BSE

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses